NUP153 | nucleoporin 153kDa | 6p22.3 | 0.54 | 0.698 | 0
|
DEK | DEK proto-oncogene | 6p23 | 0.431 | 0.611 | 0
|
SLC30A6 | solute carrier family 30 (zinc transporter), member 6 | 2p22.3 | 0.41 | 0.556 | 0
|
ASXL2 | additional sex combs like transcriptional regulator 2 | 2p24.1 | 0.407 | 0.543 | 0
|
RIF1 | replication timing regulatory factor 1 | 2q23.3 | 0.405 | 0.567 | 0
|
BARD1 | BRCA1 associated RING domain 1 | 2q35 | 0.401 | 0.52 | 0
|
RRAGC | Ras-related GTP binding C | 1p34 | 0.397 | 0.487 | 0
|
STRN | striatin, calmodulin binding protein | 2p22.2 | 0.393 | 0.577 | 0
|
TAF13 | TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa | 1p13.3 | 0.392 | 0.463 | 0
|
GTF3C4 | general transcription factor IIIC, polypeptide 4, 90kDa | 9q34.3 | 0.39 | 0.542 | 0
|
GPATCH11 | G patch domain containing 11 | 2p22.2 | 0.389 | 0.563 | 0
|
PRR11 | proline rich 11 | 17q23.2 | 0.388 | 0.548 | 0
|
RBL1 | retinoblastoma-like 1 | 20q11.23 | 0.388 | 0.507 | 0
|
MOB1A | MOB kinase activator 1A | 2p13.1 | 0.385 | 0.548 | 0
|
ZNF281 | zinc finger protein 281 | 1q32.1 | 0.382 | 0.545 | 0
|
HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | 6p24-p22.3 | 0.379 | 0.519 | 0
|
ARMC1 | armadillo repeat containing 1 | 8q12.3 | 0.379 | 0.512 | 0
|
BLOC1S1 | biogenesis of lysosomal organelles complex-1, subunit 1 | 12q13-q14 | 0.374 | -0.515 | 0
|
CLSPN | claspin | 1p34.3 | 0.374 | 0.514 | 0
|
TNPO3 | transportin 3 | 7q32.2 | 0.371 | 0.553 | 0
|
SLC25A24 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 | 1p13.2 | 0.37 | 0.476 | 0
|
UBXN7 | UBX domain protein 7 | 3q29 | 0.368 | 0.536 | 0
|
NUP160 | nucleoporin 160kDa | 11p11.12 | 0.367 | 0.532 | 0
|
ACTR2 | ARP2 actin-related protein 2 homolog (yeast) | 2p14 | 0.364 | 0.519 | 0
|
TCEB2 | transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) | 16p12.3 | 0.364 | -0.506 | 0
|
DHX9 | DEAH (Asp-Glu-Ala-His) box helicase 9 | 1q25 | 0.364 | 0.489 | 0
|
NUP155 | nucleoporin 155kDa | 5p13.1 | 0.363 | 0.541 | 0
|
CASC5 | cancer susceptibility candidate 5 | 15q14 | 0.363 | 0.523 | 0
|
USP32 | ubiquitin specific peptidase 32 | 17q23.3 | 0.36 | 0.508 | 0
|
USP1 | ubiquitin specific peptidase 1 | 1p31.3 | 0.36 | 0.487 | 0
|
KIF13A | kinesin family member 13A | 6p23 | 0.359 | 0.522 | 0
|
PRIM2 | primase, DNA, polypeptide 2 (58kDa) | 6p12-p11.1 | 0.349 | 0.507 | 0
|
CELF1 | CUGBP, Elav-like family member 1 | 11p11 | 0.346 | 0.51 | 0
|
ATL2 | atlastin GTPase 2 | 2p22.3 | 0.345 | 0.565 | 0
|
SMDT1 | single-pass membrane protein with aspartate-rich tail 1 | 22q13.2 | 0.345 | -0.5 | 0
|
SMC6 | structural maintenance of chromosomes 6 | 2p24.3 | 0.344 | 0.519 | 0
|
NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | 1p13.2 | 0.344 | 0.523 | 0
|
USP42 | ubiquitin specific peptidase 42 | 7p22.2 | 0.344 | 0.482 | 0
|
CKAP2L | cytoskeleton associated protein 2-like | 2q13 | 0.344 | 0.487 | 0
|
ALMS1 | Alstrom syndrome protein 1 | 2p13.1 | 0.343 | 0.472 | 0
|
MSH2 | mutS homolog 2 | 2p21 | 0.343 | 0.506 | 0
|
RAD18 | RAD18 E3 ubiquitin protein ligase | 3p25.3 | 0.342 | 0.497 | 0
|
CXorf56 | chromosome X open reading frame 56 | Xq24 | 0.342 | 0.413 | 0
|
UTP20 | UTP20, small subunit (SSU) processome component, homolog (yeast) | 12q23 | 0.341 | 0.457 | 0
|
LRRC40 | leucine rich repeat containing 40 | 1p31.1 | 0.34 | 0.44 | 0
|
NUP205 | nucleoporin 205kDa | 7q31.32 | 0.34 | 0.519 | 0
|
CKAP5 | cytoskeleton associated protein 5 | 11p11.2 | 0.339 | 0.503 | 0
|
BRCA2 | breast cancer 2, early onset | 13q13.1 | 0.338 | 0.463 | 0
|
KIAA1551 | KIAA1551 | 12p11.21 | 0.336 | 0.375 | 8.97e-16
|
ACLY | ATP citrate lyase | 17q21.2 | 0.335 | 0.459 | 0
|
NPEPL1 | aminopeptidase-like 1 | 20q13.32 | 0.335 | -0.451 | 0
|
NDUFB10 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa | 16p13.3 | 0.332 | -0.458 | 0
|
PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 3q29 | 0.329 | 0.486 | 0
|
ANAPC1 | anaphase promoting complex subunit 1 | 2q12.1 | 0.328 | 0.487 | 0
|
MCM8 | minichromosome maintenance 8 homologous recombination repair factor | 20p12.3 | 0.327 | 0.46 | 0
|
NDUFB8 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa | 10q24.31 | 0.327 | -0.442 | 0
|
CDC5L | cell division cycle 5-like | 6p21.1 | 0.327 | 0.485 | 0
|
PPP4R3B | protein phosphatase 4, regulatory subunit 3B | 2p16.1 | 0.326 | 0.528 | 0
|
NPDC1 | neural proliferation, differentiation and control, 1 | 9q34.3 | 0.326 | -0.48 | 0
|
RPL7L1 | ribosomal protein L7-like 1 | 6p21.1 | 0.324 | 0.466 | 0
|
RANBP9 | RAN binding protein 9 | 6p23 | 0.324 | 0.546 | 0
|
URB2 | URB2 ribosome biogenesis 2 homolog (S. cerevisiae) | 1q42.13 | 0.324 | 0.463 | 0
|
SYTL1 | synaptotagmin-like 1 | 1p35.3 | 0.324 | -0.342 | 4.98e-13
|
ESF1 | ESF1 nucleolar pre-rRNA processing protein homolog | 20p12.1 | 0.322 | 0.435 | 0
|
NDUFA1 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa | Xq24 | 0.322 | -0.447 | 0
|
RPS2 | ribosomal protein S2 | 16p13.3 | 0.321 | -0.35 | 1.26e-13
|
TXN2 | thioredoxin 2 | 22q13.1 | 0.321 | -0.421 | 0
|
MSRB2 | methionine sulfoxide reductase B2 | 10p12 | 0.32 | -0.341 | 6.4e-13
|
TPMT | thiopurine S-methyltransferase | 6p22.3 | 0.318 | 0.539 | 0
|
CEBPZ | CCAAT/enhancer binding protein (C/EBP), zeta | 2p22.3 | 0.318 | 0.484 | 0
|
COX4I2 | cytochrome c oxidase subunit IV isoform 2 (lung) | 20q11.21 | 0.318 | -0.446 | 0
|
CCDC138 | coiled-coil domain containing 138 | 2q13 | 0.317 | 0.497 | 0
|
PIGQ | phosphatidylinositol glycan anchor biosynthesis, class Q | 16p13.3 | 0.317 | -0.384 | 6.34e-17
|
SPG7 | spastic paraplegia 7 (pure and complicated autosomal recessive) | 16q24.3 | 0.317 | -0.401 | 0
|
GSTCD | glutathione S-transferase, C-terminal domain containing | 4q24 | 0.316 | 0.474 | 0
|
TTC26 | tetratricopeptide repeat domain 26 | 7q34 | 0.315 | 0.487 | 0
|
CAPRIN1 | cell cycle associated protein 1 | 11p13 | 0.315 | 0.443 | 0
|
USP14 | ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) | 18p11.32 | 0.315 | 0.46 | 0
|
YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta | 2p25.2-p25.1 | 0.314 | 0.444 | 0
|
MDP1 | magnesium-dependent phosphatase 1 | 14q12 | 0.314 | -0.49 | 0
|
SELO | | | 0.313 | -0.407 | 0
|
GART | phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | 21q22.11 | 0.313 | 0.451 | 0
|
TRIM37 | tripartite motif containing 37 | 17q | 0.312 | 0.456 | 0
|
ZNF131 | zinc finger protein 131 | 5p12 | 0.312 | 0.368 | 4.26e-15
|
CDK10 | cyclin-dependent kinase 10 | 16q24.3 | 0.312 | -0.369 | 3.48e-15
|
SLC4A1AP | solute carrier family 4 (anion exchanger), member 1, adaptor protein | 2p23.3 | 0.312 | 0.466 | 0
|
HELB | helicase (DNA) B | 12q14.2 | 0.311 | 0.488 | 0
|
JMJD8 | jumonji domain containing 8 | 16p13.3 | 0.311 | -0.487 | 0
|
GNAI3 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 | 1p13 | 0.311 | 0.412 | 0
|
KPNB1 | karyopherin (importin) beta 1 | 17q21.32 | 0.31 | 0.441 | 0
|
EAF1 | ELL associated factor 1 | 3p25.1 | 0.309 | 0.453 | 0
|
CRLF3 | cytokine receptor-like factor 3 | 17q11.2 | 0.307 | 0.524 | 0
|
PRKD3 | protein kinase D3 | 2p21 | 0.307 | 0.485 | 0
|
ROM1 | retinal outer segment membrane protein 1 | 11q13 | 0.307 | -0.466 | 0
|
SPAST | spastin | 2p24-p21 | 0.307 | 0.446 | 0
|
COMMD2 | COMM domain containing 2 | 3q25.1 | 0.306 | 0.368 | 4.65e-15
|
PATL1 | protein associated with topoisomerase II homolog 1 (yeast) | 11q12.1 | 0.306 | 0.472 | 0
|
XPO5 | exportin 5 | 6p21.1 | 0.303 | 0.426 | 0
|
KPNA4 | karyopherin alpha 4 (importin alpha 3) | 3q25.33 | 0.302 | 0.407 | 0
|
JARID2 | jumonji, AT rich interactive domain 2 | 6p24-p23 | 0.301 | 0.497 | 0
|
SIRT3 | sirtuin 3 | 11p15.5 | 0.299 | -0.325 | 7.43e-12
|
STK4 | serine/threonine kinase 4 | 20q11.2-q13.2 | 0.299 | 0.387 | 0
|
FBXW4 | F-box and WD repeat domain containing 4 | 10q24 | 0.299 | -0.47 | 0
|
E2F3 | E2F transcription factor 3 | 6p22 | 0.298 | 0.438 | 0
|
TMEM205 | transmembrane protein 205 | 19p13.2 | 0.297 | -0.433 | 0
|
CSTF2 | cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa | Xq22.1 | 0.295 | 0.404 | 0
|
HMMR | hyaluronan-mediated motility receptor (RHAMM) | 5q34 | 0.295 | 0.368 | 4.64e-15
|
ITPR3 | inositol 1,4,5-trisphosphate receptor, type 3 | 6p21.31 | 0.294 | 0.39 | 0
|
MDC1 | mediator of DNA-damage checkpoint 1 | 6p21.3 | 0.287 | 0.436 | 0
|
ATOH8 | atonal bHLH transcription factor 8 | 2p11.2 | 0.286 | -0.42 | 0
|
CHADL | chondroadherin-like | 22q13.2 | 0.285 | -0.397 | 0
|
LRRC29 | leucine rich repeat containing 29 | 16q22.1 | 0.285 | -0.47 | 0
|
TMEM129 | transmembrane protein 129, E3 ubiquitin protein ligase | 4p16.3 | 0.283 | -0.441 | 0
|
BLM | Bloom syndrome, RecQ helicase-like | 15q26.1 | 0.281 | 0.293 | 8.48e-10
|
KIF15 | kinesin family member 15 | 3p21.31 | 0.281 | 0.399 | 0
|
DHRS4L2 | dehydrogenase/reductase (SDR family) member 4 like 2 | 14q11.2 | 0.28 | -0.355 | 5.16e-14
|
IGFBP4 | insulin-like growth factor binding protein 4 | 17q21.2 | 0.279 | -0.438 | 0
|
TARBP2 | TAR (HIV-1) RNA binding protein 2 | 12q13.13 | 0.276 | -0.283 | 3.27e-09
|
OTX1 | orthodenticle homeobox 1 | 2p15 | 0.276 | 0.398 | 0
|
EPB41L4A-AS1 | EPB41L4A antisense RNA 1 | 5q22.2 | 0.275 | -0.395 | 0
|
CDKAL1 | CDK5 regulatory subunit associated protein 1-like 1 | 6p22.2 | 0.273 | 0.435 | 0
|
MSRA | methionine sulfoxide reductase A | 8p23.1 | 0.272 | -0.42 | 0
|
CAD | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 2p22-p21 | 0.272 | 0.401 | 0
|
CLEC3B | C-type lectin domain family 3, member B | 3p22-p21.3 | 0.271 | -0.406 | 0
|
RRP1B | ribosomal RNA processing 1B | 21q22.3 | 0.27 | 0.464 | 0
|
EFCC1 | EF-hand and coiled-coil domain containing 1 | 3q21.3 | 0.27 | -0.307 | 1.06e-10
|
CMPK1 | cytidine monophosphate (UMP-CMP) kinase 1, cytosolic | 1p34.1-p33 | 0.269 | 0.289 | 1.47e-09
|
SMIM13 | small integral membrane protein 13 | 6p24.2 | 0.268 | 0.396 | 0
|
TADA2A | transcriptional adaptor 2A | 17q12-q21 | 0.268 | 0.328 | 4.56e-12
|
GPN1 | GPN-loop GTPase 1 | 2p23.3 | 0.268 | 0.418 | 0
|
DDX52 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 | 17q12 | 0.268 | 0.44 | 0
|
LOXL1 | lysyl oxidase-like 1 | 15q24-q25 | 0.267 | -0.352 | 9.46e-14
|
TMEM88 | transmembrane protein 88 | 17p13.1 | 0.266 | -0.382 | 1.39e-16
|
ALG12 | ALG12, alpha-1,6-mannosyltransferase | 22q13.33 | 0.265 | -0.35 | 1.24e-13
|
LMO2 | LIM domain only 2 (rhombotin-like 1) | 11p13 | 0.264 | -0.314 | 3.87e-11
|
SCGB3A1 | secretoglobin, family 3A, member 1 | 5q35.3 | 0.264 | -0.373 | 1.41e-15
|
PHGR1 | proline/histidine/glycine-rich 1 | 15q15.1 | 0.263 | -0.301 | 2.84e-10
|
PAK1IP1 | PAK1 interacting protein 1 | 6p24.1 | 0.263 | 0.413 | 0
|
CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 17q12 | 0.263 | 0.48 | 0
|
EXOC2 | exocyst complex component 2 | 6p25.3 | 0.26 | 0.431 | 0
|
CYB5D2 | cytochrome b5 domain containing 2 | 17p13.2 | 0.258 | -0.335 | 1.7e-12
|
DNAJC21 | DnaJ (Hsp40) homolog, subfamily C, member 21 | 5p13.2 | 0.257 | 0.356 | 4.61e-14
|
RNF144B | ring finger protein 144B | 6p22.3 | 0.256 | 0.37 | 2.76e-15
|
HOXB4 | homeobox B4 | 17q21.32 | 0.256 | -0.213 | 9.48e-06
|
CD3EAP | CD3e molecule, epsilon associated protein | 19q13.3 | 0.255 | 0.343 | 3.94e-13
|
CCDC112 | coiled-coil domain containing 112 | 5q22.3 | 0.252 | 0.373 | 1.37e-15
|
FAM8A1 | family with sequence similarity 8, member A1 | 6p23 | 0.25 | 0.354 | 5.91e-14
|
SLC7A6OS | solute carrier family 7, member 6 opposite strand | 16q22.1 | 0.248 | 0.375 | 8.62e-16
|
C21orf91 | chromosome 21 open reading frame 91 | 21q21.1 | 0.247 | 0.377 | 5.08e-16
|
SSR1 | signal sequence receptor, alpha | 6p24.3 | 0.246 | 0.41 | 0
|
HOXD9 | homeobox D9 | 2q31.1 | 0.243 | -0.402 | 0
|
CD83 | CD83 molecule | 6p23 | 0.241 | 0.277 | 7.19e-09
|
CPLX1 | complexin 1 | 4p16.3 | 0.241 | -0.348 | 1.76e-13
|
MYOM2 | myomesin 2 | 8p23.3 | 0.239 | -0.317 | 2.54e-11
|
CIB1 | calcium and integrin binding 1 (calmyrin) | 15q25.3-q26 | 0.237 | -0.388 | 0
|
TGFA | transforming growth factor, alpha | 2p13 | 0.236 | 0.306 | 1.35e-10
|
MAP6 | microtubule-associated protein 6 | 11q13.5 | 0.236 | -0.234 | 1.12e-06
|
BLOC1S5 | biogenesis of lysosomal organelles complex-1, subunit 5, muted | 6p25.1-p24.3 | 0.231 | 0.393 | 0
|
SYT9 | synaptotagmin IX | 11p15.4 | 0.231 | -0.268 | 2.21e-08
|
LPCAT4 | lysophosphatidylcholine acyltransferase 4 | 15q14 | 0.231 | -0.283 | 3.04e-09
|
DHX16 | DEAH (Asp-Glu-Ala-His) box polypeptide 16 | 6p21.3 | 0.23 | 0.306 | 1.24e-10
|
CLP1 | cleavage and polyadenylation factor I subunit 1 | 11q12.1 | 0.227 | 0.261 | 5.18e-08
|
KIF3C | kinesin family member 3C | 2p23 | 0.225 | 0.313 | 5e-11
|
BTNL9 | butyrophilin-like 9 | 5q35.3 | 0.224 | -0.182 | 0.000158
|
AVPI1 | arginine vasopressin-induced 1 | 10q24.2 | 0.218 | -0.287 | 1.72e-09
|
WRNIP1 | Werner helicase interacting protein 1 | 6p25.2 | 0.216 | 0.258 | 7.52e-08
|
ANO2 | anoctamin 2, calcium activated chloride channel | 12p13.3 | 0.215 | -0.29 | 1.18e-09
|
TRMT6 | tRNA methyltransferase 6 | 20p12.3 | 0.213 | 0.339 | 8.62e-13
|
CLN5 | ceroid-lipofuscinosis, neuronal 5 | 13q21.2-q32 | 0.212 | -0.052 | 0.284
|
NHLRC1 | NHL repeat containing E3 ubiquitin protein ligase 1 | 6p22.3 | 0.198 | 0.233 | 1.18e-06
|
RTCA | RNA 3'-terminal phosphate cyclase | 1p13.3 | 0.188 | 0.253 | 1.23e-07
|